Drug Information

Drug General Information
Drug ID
D0L5MW
Former ID
DNC010258
Drug Name
(+/-)-nantenine
Indication Discovery agent Investigative [530558]
Structure
Download
2D MOL

3D MOL
Canonical SMILES
CC(=O)C1=CC2=C3C(CC4=CC5=C(C=C4C3=C1C(=O)C)OCO5)N(CC2)C
InChI
1S/C22H21NO4/c1-11(24)15-6-13-4-5-23(3)17-7-14-8-18-19(27-10-26-18)9-16(14)22(21(13)17)20(15)12(2)25/h6,8-9,17H,4-5,7,10H2,1-3H3
InChIKey
QBCMSGDOKGQABG-UHFFFAOYSA-N
Target and Pathway
Target(s) D(4) dopamine receptor Target Info Inhibitor [530558]
Alpha-2C adrenergic receptor Target Info Inhibitor [530558]
D(2) dopamine receptor Target Info Inhibitor [530558]
5-hydroxytryptamine 7 receptor Target Info Inhibitor [530558]
Sodium-dependent serotonin transporter Target Info Inhibitor [530558]
Alpha-2B adrenergic receptor Target Info Inhibitor [530558]
Alpha-1A adrenergic receptor Target Info Inhibitor [530558]
5-hydroxytryptamine 2B receptor Target Info Inhibitor [530558]
5-hydroxytryptamine 2A receptor Target Info Inhibitor [530558]
5-hydroxytryptamine 6 receptor Target Info Inhibitor [530558]
Dopamine D1 receptor Target Info Inhibitor [530558]
5-hydroxytryptamine 1D receptor Target Info Inhibitor [530558]
Alpha-1D adrenergic receptor Target Info Inhibitor [530558]
D(3) dopamine receptor Target Info Inhibitor [530558]
Mu-type opioid receptor Target Info Inhibitor [530558]
D(1B) dopamine receptor Target Info Inhibitor [530558]
Histamine H2 receptor Target Info Inhibitor [530558]
5-hydroxytryptamine 5A receptor Target Info Inhibitor [530558]
Alpha-1B adrenergic receptor Target Info Inhibitor [530558]
Beta-1 adrenergic receptor Target Info Inhibitor [530558]
5-hydroxytryptamine 1B receptor Target Info Inhibitor [530558]
5-hydroxytryptamine 2C receptor Target Info Inhibitor [530558]
Alpha-2A adrenergic receptor Target Info Inhibitor [530558]
KEGG Pathway Neuroactive ligand-receptor interaction
Dopaminergic synapsehsa04022:cGMP-PKG signaling pathway
Neuroactive ligand-receptor interactionhsa04015:Rap1 signaling pathway
cAMP signaling pathway
Gap junction
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Alcoholismhsa04014:Ras signaling pathway
Calcium signaling pathway
Serotonergic synapsehsa04726:Serotonergic synapsehsa04022:cGMP-PKG signaling pathway
Neuroactive ligand-receptor interactionhsa04020:Calcium signaling pathway
cGMP-PKG signaling pathway
AMPK signaling pathway
Adrenergic signaling in cardiomyocytes
Vascular smooth muscle contraction
Salivary secretionhsa04020:Calcium signaling pathway
Serotonergic synapse
Inflammatory mediator regulation of TRP channelshsa04020:Calcium signaling pathway
Serotonergic synapsehsa04020:Calcium signaling pathway
Amphetamine addiction
Morphine addiction
Alcoholismhsa04024:cAMP signaling pathway
Salivary secretionhsa04080:Neuroactive ligand-receptor interaction
Dopaminergic synapsehsa04080:Neuroactive ligand-receptor interaction
Estrogen signaling pathway
Morphine addictionhsa04020:Calcium signaling pathway
Dopaminergic synapsehsa04020:Calcium signaling pathway
Gastric acid secretionhsa04020:Calcium signaling pathway
Endocytosis
Salivary secretion
Dilated cardiomyopathyhsa04024:cAMP signaling pathway
Inflammatory mediator regulation of TRP channelshsa04022:cGMP-PKG signaling pathway
NetPath Pathway TCR Signaling PathwayNetPath_14:IL2 Signaling PathwayNetPath_11:TCR Signaling PathwayNetPath_14:IL2 Signaling Pathway
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Dopamine receptor mediated signaling pathway
Nicotine pharmacodynamics pathwayP00002:Alpha adrenergic receptor signaling pathway
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Nicotine pharmacodynamics pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP04373:5HT1 type receptor mediated signaling pathway
5HT2 type receptor mediated signaling pathway
5HT3 type receptor mediated signaling pathway
5HT4 type receptor mediated signaling pathwayP00002:Alpha adrenergic receptor signaling pathway
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP00002:Alpha adrenergic receptor signaling pathwayP04374:5HT2 type receptor mediated signaling pathwayP04374:5HT2 type receptor mediated signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP05912:Dopamine receptor mediated signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
5HT1 type receptor mediated signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Enkephalin releaseP05912:Dopamine receptor mediated signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Histamine H2 receptor mediated signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP00002:Alpha adrenergic receptor signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Beta1 adrenergic receptor signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
5HT1 type receptor mediated signaling pathwayP04374:5HT2 type receptor mediated signaling pathwayP00002:Alpha adrenergic receptor signaling pathway
Pathway Interaction Database IL4-mediated signaling eventslysophospholipid_pathway:LPA receptor mediated events
PathWhiz Pathway Excitatory Neural Signalling Through 5-HTR 7 and SerotoninPW000444:Excitatory Neural Signalling Through 5-HTR 6 and SerotoninPW000440:Dopamine Activation of Neurological Reward SystemPW000449:Intracellular Signalling Through Histamine H2 Receptor and Histamine
Gastric Acid ProductionPW000564:Muscle/Heart Contraction
Reactome Dopamine receptors
G alpha (i) signalling eventsR-HSA-390696:Adrenoceptors
Adrenaline signalling through Alpha-2 adrenergic receptor
Adrenaline,noradrenaline inhibits insulin secretion
G alpha (i) signalling events
G alpha (z) signalling events
Surfactant metabolismR-HSA-390651:Dopamine receptors
G alpha (i) signalling eventsR-HSA-390666:Serotonin receptors
G alpha (s) signalling eventsR-HSA-390696:Adrenoceptors
G alpha (z) signalling eventsR-HSA-390696:Adrenoceptors
G alpha (q) signalling events
G alpha (12/13) signalling eventsR-HSA-390666:Serotonin receptors
G alpha (q) signalling eventsR-HSA-390666:Serotonin receptors
G alpha (s) signalling eventsR-HSA-390651:Dopamine receptors
G alpha (s) signalling eventsR-HSA-390666:Serotonin receptors
G alpha (12/13) signalling eventsR-HSA-390651:Dopamine receptors
G alpha (i) signalling eventsR-HSA-375276:Peptide ligand-binding receptors
G alpha (i) signalling eventsR-HSA-390651:Dopamine receptors
G alpha (s) signalling eventsR-HSA-390650:Histamine receptors
G alpha (12/13) signalling eventsR-HSA-390696:Adrenoceptors
G alpha (q) signalling eventsR-HSA-390696:Adrenoceptors
Surfactant metabolism
WikiPathways Hypothetical Network for Drug Addiction
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Genes and (Common) Pathways Underlying Drug Addiction
GPCR ligand binding
GPCR downstream signaling
Nicotine Activity on Dopaminergic Neurons
GPCRs, OtherWP58:Monoamine GPCRs
Platelet Aggregation (Plug Formation)
Integration of energy metabolism
GPCR downstream signalingWP666:Hypothetical Network for Drug Addiction
Nicotine Activity on Dopaminergic NeuronsWP734:Serotonin Receptor 4/6/7 and NR3C Signaling
GPCRs, OtherWP727:Monoamine Transport
SIDS Susceptibility Pathways
NRF2 pathway
Synaptic Vesicle Pathway
Serotonin Transporter ActivityWP58:Monoamine GPCRs
GPCR downstream signalingWP58:Monoamine GPCRs
Calcium Regulation in the Cardiac Cell
Gastrin-CREB signalling pathway via PKC and MAPK
Endothelin Pathways
AMPK SignalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
GPCRs, OtherWP734:Serotonin Receptor 4/6/7 and NR3C Signaling
GPCR downstream signalingWP722:Serotonin HTR1 Group and FOS Pathway
GPCRs, OtherWP69:TCR Signaling Pathway
Peptide GPCRs
Opioid Signalling
Secretion of Hydrochloric Acid in Parietal Cells
Vitamin D Receptor Pathway
AMPK SignalingWP58:Monoamine GPCRs
GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
References
Ref 530558Bioorg Med Chem Lett. 2010 Jan 15;20(2):628-31. Epub 2009 Nov 20.Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.
Ref 530558Bioorg Med Chem Lett. 2010 Jan 15;20(2):628-31. Epub 2009 Nov 20.Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.